Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Isacchi A"'
Autor:
Somaschini A; NMS Oncology, Nerviano Medical Sciences, NMS Group, 20014, Nerviano, Milan, Italy., Di Bella S; NMS Oncology, Nerviano Medical Sciences, NMS Group, 20014, Nerviano, Milan, Italy., Cusi C; NMS Oncology, Nerviano Medical Sciences, NMS Group, 20014, Nerviano, Milan, Italy., Raddrizzani L; NMS Oncology, Nerviano Medical Sciences, NMS Group, 20014, Nerviano, Milan, Italy., Leone A; NMS Oncology, Nerviano Medical Sciences, NMS Group, 20014, Nerviano, Milan, Italy., Carapezza G; NMS Oncology, Nerviano Medical Sciences, NMS Group, 20014, Nerviano, Milan, Italy., Mazza T; Bioinformatics Unit, IRCCS 'Casa Sollievo della Sofferenza', Research Hospital, San Giovanni Rotondo, Italy., Isacchi A; NMS Oncology, Nerviano Medical Sciences, NMS Group, 20014, Nerviano, Milan, Italy., Bosotti R; NMS Oncology, Nerviano Medical Sciences, NMS Group, 20014, Nerviano, Milan, Italy. roberta.bosotti@nervianoms.com.
Publikováno v:
Scientific data [Sci Data] 2020 Nov 30; Vol. 7 (1), pp. 420. Date of Electronic Publication: 2020 Nov 30.
Autor:
Ukmar G; NMS Oncology, Nerviano Medical Sciences Srl, Nerviano, Italy., Melloni GEM; University of Milano Bicocca, Milano, Italy., Raddrizzani L; NMS Oncology, Nerviano Medical Sciences Srl, Nerviano, Italy., Rossi P; Icona Srl, Cinisello Balsamo, Italy., Di Bella S; NMS Oncology, Nerviano Medical Sciences Srl, Nerviano, Italy., Pirchio MR; Icona Srl, Cinisello Balsamo, Italy., Vescovi M; Parametric Design Biotech, Gessate, Italy., Leone A; NMS Oncology, Nerviano Medical Sciences Srl, Nerviano, Italy., Callari M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Cesarini M; University of Milano Bicocca, Milano, Italy., Somaschini A; NMS Oncology, Nerviano Medical Sciences Srl, Nerviano, Italy., Della Vedova G; University of Milano Bicocca, Milano, Italy., Daidone MG; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Pettenella M; Parametric Design Biotech, Gessate, Italy., Isacchi A; NMS Oncology, Nerviano Medical Sciences Srl, Nerviano, Italy., Bosotti R; NMS Oncology, Nerviano Medical Sciences Srl, Nerviano, Italy.
Publikováno v:
BioMed research international [Biomed Res Int] 2018 Jun 28; Vol. 2018, pp. 2012078. Date of Electronic Publication: 2018 Jun 28 (Print Publication: 2018).
Autor:
Weiss GJ; Western Regional Medical Center, Cancer Treatment Centers of America, 14200 W Celebrate Life Way, Goodyear, AZ, 85338, USA. drglenweiss@outlook.com.; Virginia G. Piper Cancer Centers at Scottsdale Healthcare, Scottsdale, AZ, USA. drglenweiss@outlook.com., Jameson G; Virginia G. Piper Cancer Centers at Scottsdale Healthcare, Scottsdale, AZ, USA., Von Hoff DD; Virginia G. Piper Cancer Centers at Scottsdale Healthcare, Scottsdale, AZ, USA., Valsasina B; Nerviano Medical Sciences S.r.l., Nerviano, Italy., Davite C; CLInical Organization for Strategies and Solutions (CLIOSS) S.r.l, Mayo Scottsdale, Nerviano, Italy., Di Giulio C; CLInical Organization for Strategies and Solutions (CLIOSS) S.r.l, Mayo Scottsdale, Nerviano, Italy., Fiorentini F; Accelera S.r.l, Nerviano, Italy., Alzani R; Nerviano Medical Sciences S.r.l., Nerviano, Italy., Carpinelli P; Nerviano Medical Sciences S.r.l., Nerviano, Italy., Di Sanzo A; CLInical Organization for Strategies and Solutions (CLIOSS) S.r.l, Mayo Scottsdale, Nerviano, Italy., Galvani A; Nerviano Medical Sciences S.r.l., Nerviano, Italy., Isacchi A; Nerviano Medical Sciences S.r.l., Nerviano, Italy., Ramanathan RK; Virginia G. Piper Cancer Centers at Scottsdale Healthcare, Scottsdale, AZ, USA.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2018 Feb; Vol. 36 (1), pp. 85-95. Date of Electronic Publication: 2017 Jul 20.
Autor:
Nuzzo A; Business Unit Oncology, Nerviano Medical Sciences srl, Nerviano, MI, 20014, Italy.; Department of Bioengineering, University of Applied Sciences, Vienna, 1190, Austria., Carapezza G; Business Unit Oncology, Nerviano Medical Sciences srl, Nerviano, MI, 20014, Italy., Di Bella S; Business Unit Oncology, Nerviano Medical Sciences srl, Nerviano, MI, 20014, Italy., Pulvirenti A; Department of Clinical and Experimental Medicine, University of Catania, Catania, 95125, Italy., Isacchi A; Business Unit Oncology, Nerviano Medical Sciences srl, Nerviano, MI, 20014, Italy., Bosotti R; Business Unit Oncology, Nerviano Medical Sciences srl, Nerviano, MI, 20014, Italy. roberta.bosotti@nervianoms.com.
Publikováno v:
BMC bioinformatics [BMC Bioinformatics] 2016 Nov 08; Vol. 17 (Suppl 12), pp. 340. Date of Electronic Publication: 2016 Nov 08.
Autor:
Magnaghi P; Business Unit Oncology, Nerviano Medical Sciences, Nerviano, Italy., D'Alessio R, Valsasina B, Avanzi N, Rizzi S, Asa D, Gasparri F, Cozzi L, Cucchi U, Orrenius C, Polucci P, Ballinari D, Perrera C, Leone A, Cervi G, Casale E, Xiao Y, Wong C, Anderson DJ, Galvani A, Donati D, O'Brien T, Jackson PK, Isacchi A
Publikováno v:
Nature chemical biology [Nat Chem Biol] 2013 Sep; Vol. 9 (9), pp. 548-56. Date of Electronic Publication: 2013 Jul 28.
Autor:
Somaschini A; Business Unit Oncology, Nerviano Medical Sciences S.r.l., Nerviano (MI), Italy., Amboldi N, Nuzzo A, Scacheri E, Ukmar G, Ballinari D, Malyszko J, Raddrizzani L, Landonio A, Gasparri F, Galvani A, Isacchi A, Bosotti R
Publikováno v:
Genetic testing and molecular biomarkers [Genet Test Mol Biomarkers] 2013 Mar; Vol. 17 (3), pp. 254-9. Date of Electronic Publication: 2013 Jan 28.
Autor:
Locatelli G; Business Unit Oncology, Nerviano Medical Sciences srl, Nerviano (MI), Italy., Bosotti R, Ciomei M, Brasca MG, Calogero R, Mercurio C, Fiorentini F, Bertolotti M, Scacheri E, Scaburri A, Galvani A, Pesenti E, De Baere T, Soria JC, Lazar V, Isacchi A
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2010 May; Vol. 9 (5), pp. 1265-73. Date of Electronic Publication: 2010 Apr 27.
Autor:
Laura Raddrizzani, Antonella Leone, Giovanni Carapezza, Carlo Cusi, Alessio Somaschini, Sebastiano Di Bella, Antonella Isacchi, Tommaso Mazza, Roberta Bosotti
Publikováno v:
Scientific Data
Inhibition of kinase gene fusions (KGFs) has proven successful in cancer treatment and continues to represent an attractive research area, due to kinase druggability and clinical validation. Indeed, literature and public databases report a remarkable
Autor:
Alessandro Di Sanzo, Claudia Di Giulio, Arturo Galvani, Glen J. Weiss, Francesco Fiorentini, Barbara Valsasina, Daniel D. Von Hoff, Gayle S. Jameson, Ramesh K. Ramanathan, Cristina Davite, Rachele Alzani, Antonella Isacchi, Patrizia Carpinelli
Publikováno v:
Investigational new drugs. 36(1)
Background Pharmacological inhibition of polo-like kinase 1 (PLK1) represents a new approach for the treatment of solid tumors. This study was aimed at determining the first cycle dose-limiting toxicities (DLTs) and related maximum tolerated dose (MT
Autor:
Arturo Galvani, Nadia Amboldi, Fabio Gasparri, Antonella Isacchi, G Ukmar, Alessio Somaschini, Antonella Landonio, Angelo Nuzzo, Emanuela Scacheri, Dario Ballinari, Jan Malyszko, Laura Raddrizzani, Roberta Bosotti
Publikováno v:
Genetic Testing and Molecular Biomarkers. 17:254-259
The generation of biological data on wide panels of tumor cell lines is recognized as a valid contribution to the cancer research community. However, research laboratories can benefit from this knowledge only after the identity of each individual cel